Results 21 to 30 of about 20,675,763 (300)

Cost‐effectiveness analysis of delgocitinib in adult patients with atopic dermatitis in Japan

Journal of Cutaneous Immunology and Allergy, 2021
Objectives This study evaluated the cost‐effectiveness of delgocitinib relative to moisturization therapy in adult patients with moderate to severe atopic dermatitis. Methods The analysis was performed by using the simulation model with the patient‐level
Motoi Takenaka, Mai Matsumoto, Hiroyuki Murota, Sachie Inoue, Hidetoshi Shibahara, Kazufumi Yoshida, Sotaro Takigawa, Atsushi Ishimoto   +7 more
doaj   +1 more source

Justifying Terminal Care by 'Retrospective Quality-Adjusted Life-Years'

, 2010
A lot of medical procedures can be justified in terms of the number of quality-adjusted life-years (QALYs) they can be expected to generate; that is, the number of extra years that the procedure will provide, with the quality of life during those extra ...
Cowley, Christopher
core   +1 more source

What Matters for Well-Being: Individual Perceptions of Quality of Life Before and After Important Life Events [PDF]

, 2012
In recent decades, what matters for individual quality of life (QoL) has increasingly been the focus of empirical social science research. However, individuals are rarely asked directly what is important for their quality of life as part of large-scale ...

core   +7 more sources

The Impact of Ankle Arthritis Treatment on Quality Adjusted Life Years

Foot & Ankle Orthopaedics, 2017
Category: Ankle, Ankle Arthritis Introduction/Purpose: Patients living with end stage ankle arthritis suffer significant disability. They are two standard deviations below population scores for all symptom and function SF-36 sub-scales. In addition, they
Kelly Hynes MD, BSc, Kevin Wing MD, FRCS(C), Alastair Younger MB ChB, ChM, FRCSC, Andrea Veljkovic MD, FRCS(C), Murray Penner MD, FRCS(C), Jason Sutherland MSc, PhD   +5 more
doaj   +1 more source

Results of deterministic sensitivity analyses for incremental costs and quality-adjusted life years (QALYs).

, 2020
Results of deterministic sensitivity analyses for incremental costs and quality-adjusted life years (QALYs).
Benjamin Birkner (8212203), Jürgen Rech (3741517), Tom Stargardt (5064095)   +2 more
core   +1 more source

Incremental cost, life years gained, quality-adjusted life years and incremental cost-effectiveness ratios of 5-yearly sigmoidoscopy compared with commonly used screening measures (in 2019 $).

, 2023
Incremental cost, life years gained, quality-adjusted life years and incremental cost-effectiveness ratios of 5-yearly sigmoidoscopy compared with commonly used screening measures (in 2019 $).
Christian Krauth (3144804), Wendelin Schramm (11857538), Siegbert Rossol (3144807), Leonie Diedrich (13845958), Maren Dreier (628959), Melanie Brinkmann (16851499)   +5 more
core   +1 more source

Fundamental Measurement: The Need Fulfilment Quality of Life (N-QOL) Measure

INNOVATIONS in Pharmacy, 2021
The quality adjusted life year (QALY) has serious problems related to its failure to adhere to measurement theory. If a QALY is to be meaningful, the utility score that translates time spent to an equivalent time spent in so-called perfect health must ...
Paul C. Langley, Stephen P. McKenna
doaj   +1 more source

Results of alternative strategies: costs, life expectancy, quality-adjusted life years (QALYs) gained.

, 2016
Results of alternative strategies: costs, life expectancy, quality-adjusted life years (QALYs) gained.
Pei Liu (93392), Hua Zhang (12549), Mingdong Huo (3092376), Jianqian Chao (146997)   +3 more
core   +1 more source

Incremental cost, life years gained, quality-adjusted life years and incremental cost-effectiveness ratios of 5-yearly sigmoidoscopy compared with newer screening measures (in 2019 $).

, 2023
Incremental cost, life years gained, quality-adjusted life years and incremental cost-effectiveness ratios of 5-yearly sigmoidoscopy compared with newer screening measures (in 2019 $).
Christian Krauth (3144804), Wendelin Schramm (11857538), Siegbert Rossol (3144807), Leonie Diedrich (13845958), Maren Dreier (628959), Melanie Brinkmann (16851499)   +5 more
core   +1 more source

Monetary Valuation of a Quality-Adjusted Life Year (QALY) for Depressive Disorders Among Patients and Non-Patient Respondents: A Matched Willingness to Pay Study

Clinical Psychology in Europe, 2021
[Background] As estimated by the World Health Organization, depressive disorders will be the leading contributor to the Global Burden of Disease by 2030.
Laura Ulbrich, Christoph Kröger
doaj   +1 more source